Navigation Links
Sepsis risk increased due to the absence of one key enzyme

The presence of caspase-12, touted as the wonder enzyme in sepsis increases the bodys vulnerability to bacterial infection and septic shock while a deficiency confers strong resistance to sepsis. //

This enzyme appears to modulate inflammation and innate immunity in humans.

"The results of the study make clear that caspase-12 plays a critical role in the elimination of bacterial pathogens, and that a deficiency allows systemic and abdominal infections to be better resolved. It's known that the presence of caspase-12 as a full length protein occurs in a small percentage of people of African descent. As a result, some of these individuals are far more susceptible to severe sepsis and have a significantly increased risk of dying from it," said Richard Ulevitch, chair of the Scripps Research Immunology Department and an author of the paper. The study appears in Nature.

The new study showed that caspase-12 deficient mice were resistant to peritonitis and septic shock and were able to clear pathogenic bacteria more efficiently than mice with the enzyme.

Ulevitch said, "Without the experimental model of peritonitis perfected by John Mathison from Scripps Research, we would not have been able to differentiate between the two mouse phenotypes. Because of his work, we were able to use a surgically implanted stent in the colon that allowed a gradual occurrence of sepsis and easy identification. The resulting beneficial effect of cytokine hyper-production runs contrary to some of the current thinking in sepsis research. The general thinking is that this initial cytokine 'storm' is harmful, and that belief has been the basis of a number of unsuccessful clinical studies. In our study, cells containing caspase-12 appear to weaken the activity of caspase-1 that is normally essential for bacterial clearance and sepsis survival."

While caspase-12 was previously thought to be a key mediator of endoplasmic reticulum apoptosis, the new st
'"/>




Page: 1 2

Related medicine news :

1. Sepsis treatment functions best in difficult cases
2. Sepsis Death Reported With Mifepristone – FDA Issues Warnin
3. Researchers identify the early makers of Neonatal Sepsis
4. Drexel Research in Cytokines Could Treat Sepsis
5. Mortality increased in Sporting enthusiasts!
6. Strokes increased during squatting
7. Asthmatics at increased risk of lung cancer
8. Renal problem increased
9. Risk of hemorrhagic stroke increased in smoking individuals
10. Heart attack risk increased by depression
11. Breast cancer risk not increased by acrylamide
Post Your Comments:
Breaking Medicine Technology:Dynatronics Receives 180-Day NASDAQ Extension 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3U S News Media Group and NCQA Release 2009 10 Rankings of Americas Best Health Insurance Plans 61224 1U S News Media Group and NCQA Release 2009 10 Rankings of Americas Best Health Insurance Plans 61224 2U S News Media Group and NCQA Release 2009 10 Rankings of Americas Best Health Insurance Plans 61224 3U S News Media Group and NCQA Release 2009 10 Rankings of Americas Best Health Insurance Plans 61224 4Fred Hassan Joins Bausch 26amp 3B Lomb Board of Directors 61219 1Fred Hassan Joins Bausch 26amp 3B Lomb Board of Directors 61219 2WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 1WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 2WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 3WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 4